Schiff Glucosamine $50 Million Class Deal Gets Final Nod (1)

A $50 million class settlement in a Reckitt Benckiser LLC joint-health product suit, the largest all-cash deal in a diet supplement false advertising action, got a California federal court’s final approval Thursday.

Gordon Noboru Yamagata and others alleged Reckitt Benckiser falsely touted its Schiff Move Free Advanced glucosamine supplements by claiming the products offer benefits that they don’t provide.

The U.S. District Court for the Northern District of California certified a class in 2019.

Reckitt Benckiser agreed to pay $50 million into a fund to cover claims, attorneys’ fees, service awards, and costs.

The plaintiffs’ attorneys were awarded their requested ...